Brenda Cooperstone, M.D.

Brenda Cooperstone, M.D.

DirectoratLexeo Therapeutics· In proxies 2023–2025

Brenda Cooperstone, M.D. sits on 3 public boards.

Boards1

  • Lexeo TherapeuticsDirector · 2 yr on the boardIndependentNominating and Corporate Governance, Science and Technology (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Lexeo TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -69%
  2. Gandeeva TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Senti Biosciences, Inc.Public company · 7 yr
    • Director2019 – Present · 7 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?